Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008)-Reference-Cited by-同舟云学术

Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008)

Published:2010-02 Issue: Volume: Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

NAKAR C.,COOPER D. L.,DiMICHELE D.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2010.02208.x/fullpdf

Reference34 articles.

1. The epidemiology of inhibitors in haemophilia A: a systematic review;Wight;Haemophilia,2003

2. Inhibitors to Factor VIII—Epidemiology and Treatment

3. Inhibitor development in haemophilia B: an orphan disease in need of attention;DiMichele;Br J Haematol,2007

4. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99;Darby;J Thromb Haemost,2004

5. Intracranial haemorrhage in haemophilia A and B;Ljung;Br J Haematol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophilia A (Factor VIII Deficiency);Hematology/Oncology Clinics of North America;2021-12

2. Recent Advances in Hemostasis at the Nanoscale;Advanced Healthcare Materials;2019-11-07

3. Emergencies in Hemophilia;Clinical Pediatric Emergency Medicine;2018-06

4. Intracranial hemorrhage in congenital bleeding disorders;Blood Coagulation & Fibrinolysis;2018-01

5. Epidemiological aspects of inhibitor development in hemophilia and strategies of management;Expert Opinion on Orphan Drugs;2016-01-14